Fervent Pharmaceuticals
Fervent Pharmaceuticals is a drug development company founded in 2011, dedicated to improving women's health by developing treatments for menopause-related symptoms such as hot flashes, night sweats, and insomnia. The company focuses on innovative, non-hormonal therapies and collaborates with strategic partners to advance its pipeline of products, including FP-101, which is in clinical trials. Fervent aims to address unmet medical needs in women’s health with safe and effective solutions.
Industries
Nr. of Employees
small (1-50)
Fervent Pharmaceuticals
740 Greenville Blvd. Suite 400–151, Greenville, NC 27858
Patents
Methods and compositions for treating or preventing symptoms of hormonal variations
US-9457022-B2
View DetailsMethods and compositions for treating and preventing symptoms of hormonal variations
US-8461102-B2
View Details
Methods and compositions for treating or preventing symptoms of hormonal variations
US-9457022-B2
View DetailsMethods and compositions for treating and preventing symptoms of hormonal variations
US-8461102-B2
View DetailsProducts
FP-101
Orally dosed formulation of an existing FDA-approved compound being repurposed for treatment of vasomotor symptoms associated with menopause (hot flashes, night sweats, insomnia).
FP-101
Orally dosed formulation of an existing FDA-approved compound being repurposed for treatment of vasomotor symptoms associated with menopause (hot flashes, night sweats, insomnia).
Services
Design and operational execution of Phase II multicenter clinical trials assessing efficacy and safety in post- and peri-menopausal women.
Remote patient participation workflows and at-home trial conduct for Phase II studies.
Formulation development and production of trial-scale batches through a university-affiliated, FDA-registered manufacturing partner.
Preparation for and execution of regulatory interactions including pre-IND meetings and IND submissions, with strategy to leverage existing data under 505(b)(2).
Management of patent filings and securing patent protections across jurisdictions for a menopause-related therapeutic.
Design and operational execution of Phase II multicenter clinical trials assessing efficacy and safety in post- and peri-menopausal women.
Remote patient participation workflows and at-home trial conduct for Phase II studies.
Formulation development and production of trial-scale batches through a university-affiliated, FDA-registered manufacturing partner.
Preparation for and execution of regulatory interactions including pre-IND meetings and IND submissions, with strategy to leverage existing data under 505(b)(2).
Management of patent filings and securing patent protections across jurisdictions for a menopause-related therapeutic.
Expertise Areas
- Clinical trial management
- Decentralized / virtual trials
- Drug repurposing and oral formulation
- cGMP formulation and trial-scale manufacturing
Key Technologies
- Oral small-molecule formulation
- cGMP trial-scale manufacturing
- Decentralized/virtual clinical trial platforms
- Patient-reported outcome capture (diaries)